Abbott's TECTONIC trial shows strong 30-day outcomes for SonicForce coronary IVL system
FROM THE WIRE · FINANCE.YAHOO.COM
SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries and restore blood flow The system is designed to bring purposeful innovation…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishPositive trial data on a still investigational device could strengthen Abbott's coronary portfolio, though approval is not yet granted.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Abbott announced strong 30-day results from the TECTONIC IDE study of its investigational SonicForce system.
- 02SonicForce uses acoustic pressure waves to crack calcium in coronary arteries and restore blood flow.
- 03Approval of the investigational system would further strengthen Abbott's comprehensive coronary devices portfolio.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets